Global Insights Local Impact
Liver specialist Cyriac Abby Philips says there are no approved medicines for treating NASH or non-alcoholic steatohepatitis. Synopsis November 14 was World Diabetes Day. With over 100 million patients, India is in the grip of a diabetes tsunami. In part two of his interview, liver specialist Cyriac Abby Philips says making holistic treatments available is
Read More
Three months ago, Robert M Califf, commissioner of the US Food and Drug Administration (USFDA) visited India to strengthen efforts on development, supply, and quality of drugs. For the US, where more than nine out of 10 prescriptions dispensed are generic drugs, India is a critical partner, responsible for supplying a substantial portion of these
Read More
Cui Xiaotian, Zhao Jinzhao, Zhou Xinda, Hua Ang, Chengxi, Tan Chen, and Han Wei Liu Ping, a 25-year-old living in Beijing, is queuing up outside the obesity clinic of the Peking University People’s Hospital early one morning, seeking a doctor’s prescription for the so-called “skinny jab” — a weight loss drug that has created a
Read More
Synopsis Improving financials of hospital chains, future growth prospects of the sector itself have attracted investors to hospital stocks. But while Apollo Hospitals and Max Healthcare led the gains post Covid-19, this calendar year Narayana Hrudayalaya has outperformed other major hospital stocks with a 72% rise in its share price. What lies ahead for the
Read More
Getty Images Synopsis The irreversible lung disease is affecting a large part of India’s population, especially the elderly. It is the biggest cause of mortality after heart ailments, while the rising number of cases reported among non-smokers in rural India raises an alarm. Veteran chest surgeon and lung-transplant specialist Arvind Kumar faces a grim reality
Read More